205 related articles for article (PubMed ID: 23362108)
1. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma.
Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ
Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734
[TBL] [Abstract][Full Text] [Related]
3. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
4. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
[TBL] [Abstract][Full Text] [Related]
5. Loss of LDOC1 expression by promoter methylation in cervical cancer cells.
Buchholtz ML; Jückstock J; Weber E; Mylonas I; Dian D; Brüning A
Cancer Invest; 2013 Nov; 31(9):571-7. PubMed ID: 24125169
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
[TBL] [Abstract][Full Text] [Related]
8. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.
González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M
Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230
[TBL] [Abstract][Full Text] [Related]
10. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020
[TBL] [Abstract][Full Text] [Related]
11. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T
Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users.
Suhr ML; Dysvik B; Bruland O; Warnakulasuriya S; Amaratunga AN; Jonassen I; Vasstrand EN; Ibrahim SO
Oncol Rep; 2007 Nov; 18(5):1061-75. PubMed ID: 17914555
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.
Chiang SL; Chen PH; Lee CH; Ko AM; Lee KW; Lin YC; Ho PS; Tu HP; Wu DC; Shieh TY; Ko YC
Cancer Res; 2008 Oct; 68(20):8489-98. PubMed ID: 18922923
[TBL] [Abstract][Full Text] [Related]
15. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
[TBL] [Abstract][Full Text] [Related]
17. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z
Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]